Skip to main content

Table 3 Demographic data

From: Monocyte deactivation in neutropenic acute respiratory distress syndrome patients treated with granulocyte colony-stimulating factor

Parameter

Neutropenic patients

Non-neutropenic patients

n

10

12

Simplified Acute Physiology Score II

45 (36–57)

38 (34–62)

Age (years)

50 (41–64)

48 (38–64)

PaO2/FiO2 (mm/Hg)

160 (150–180)

150 (129–176)

Sex (male/female)

7/3

9/3

Mortality rate (%)

80

42*

Duration of neutropenia before ARDS (days)

3 (1–7)

 

Duration of neutropenia during ARDS (days)

5 (2–10)

 

Duration of treatment by G-CSF before ARDS (days)

5 (3–9)

 

Duration of sepsis before monocyte harvesting (days)

3 (0–5)

3 (1–6)

Duration of sepsis before ARDS diagnosis (days)

2 (0–5)

3 (1–5)

  1. Data are expressed as the median and quartile (25th–75th percentiles), numbers or percentages. ARDS = acute respiratory distress syndrome; G-CSF = granulocyte colony-stimulating factor. *P < 0.05 for neutropenic patients versus non-neutropenic patients using Fisher's exact test.